Clinical trials
Active, not recruiting Phase 1/2 Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 1 |
| Accendatech USA Inc. | 1 |
| Acerta Pharma BV | 1 |
| Aveta Biomics, Inc. | 1 |
| Centre Antoine Lacassagne | 1 |
| Centre Jean Perrin | 1 |
| GlaxoSmithKline | 1 |
| Hemerion Therapeutics | 1 |
| In8bio Inc. | 1 |
| Inovio Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 23 |
| Glioma | 4 |
| Brain Neoplasms | 3 |
| Gliosarcoma | 3 |
| Diffuse Intrinsic Pontine Glioma | 2 |
| Melanoma | 2 |
| Neoplasms | 2 |
| Astrocytoma | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.